Gouda - Royal Imtech N.V. (IM-AE, technical services provider in and outside Europe) is to provide the technological infrastructure in a new teaching and research building at the University of Munster in Germany, with a value of approximately 25 million euro. This came in the wake of orders to the value of around 55 million euro received in an earlier stage for providing the technological facilities in several other German research centres.
Imtech is responsible for planning, implementing and the project management of the high-tech technological infrastructure in a new teaching and research building at the University of Munster in Germany. The new building will house innovative research bodies such as the Institute of Pharmaceutical Biology & Phytochemistry, the Institute of Pharmaceutical & Medicinal Chemistry, and the Institute of Pharmaceutical Technology & Biopharmacy, and will replace the former premises that no longer met today's teaching and research requirements. The new building will have a surface area of more than 11,000 m² and will offer state-of-the-art research facilities for professors, teachers, and students.
Imtech is providing a total solution that covers water and wastewater, heating and cooling, air-conditioning, gas (including the supply of special gases for research purposes), electricity, telecommunications, and building automation, as well as the complete laboratory infrastructure and laboratory equipment. Sustainable energy provision is also an integral part of the Imtech assignment. The highest gas-related safety standards for German laboratories and research institutes will be factored into the project.
Earlier, Imtech received orders for high-tech technology solutions in, among other places, the Skylab in Heidelberg, the Max-Planck-Institut für Eisenforschung (MPIE) in Düsseldorf, the Fraunhofer Institut ISE in Freiburg and the Karlsruher Institut für Technologie (KIT) in Karlsruhe, the laboratory of the University of Heidelberg and the extension of the laboratory research facilities of the Berlin biotech park.
0-0-0-0-0-0-0-0-0
| More information | |
| Media: | Analysts & Investors: |
| Pieter Koenders Director Corporate Communications T: +31 655 74 65 85 E: pieter.koenders@imtech.eu (mailto:pieter.koenders@imtech.eu) www.imtech.eu (http://www.imtech.eu) | Jeroen Leenaers Manager Investor Relations T: +31 182 54 35 04 E: jeroen.leenaers@imtech.eu (mailto:jeroen.leenaers@imtech.eu) www.imtech.eu (http://www.imtech.eu) |
Imtech profile
Imtech N.V. is a European technical services provider in the fields of electrical solutions, ICT (information and communication technology) and mechanical solutions. With 28,600 employees, Imtech achieves annual revenue of more than 5.1 billion euro. Imtech holds strong positions in the buildings and industry markets in the Netherlands, Belgium, Luxembourg, Germany, Austria, Eastern Europe, Sweden, Norway, Finland, the UK, Ireland, Turkey and Spain, the European markets of ICT and Traffic as well as in the global marine market. In total Imtech serves 23,000 customers. Imtech offers added value with integrated and multidisciplinary total solutions that lead to better business processes and more efficiency for customers and the customers they, in their turn, serve. Imtech also offers solutions that contribute towards a sustainable society, for example in the areas of energy, the environment, water and mobility. Imtech shares are listed on the NYSE Euronext Amsterdam, where Imtech is included in the Midkap Index. Imtech shares are also included in the Dow Jones STOXX 600 index. In 2011 Imtech has been granted the designation Royal.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Imtech N.V. via Thomson Reuters ONE
